Osteoporosis: Pathophysiology and non-pharmacological management

Best Practice and Research: Clinical Rheumatology

Volumn 15, Issue 5, 2001, Pages 727-745

  Mundy, Gregory R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone; Calcium; Fractures; Osteporosis; Soy proteins

Indexed keywords

ANTIESTROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTRADIOL; ESTROGEN; FLUORIDE; GENISTEIN; PARATHYROID HORMONE; SEX HORMONE; SOYBEAN PROTEIN; VITAMIN D;

AGING; BONE ATROPHY; BONE MASS; CLINICAL FEATURE; CLINICAL TRIAL; DIETARY INTAKE; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG COST; ELDERLY CARE; EXPERIMENTAL MODEL; HIGH RISK PATIENT; HIP FRACTURE; HORMONE BLOOD LEVEL; HUMAN; LIFESTYLE; NONHUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; POPULATION RESEARCH; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DIET; PUBLIC HEALTH; REVIEW; RISK FACTOR; SPINE FRACTURE; VITAMIN SUPPLEMENTATION;

EID: 0035691325     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2001.0190     Document Type: Article

References (94)

1. What is vertebral fracture
2. Classification of vertebral fractures
3. Boning up on genes
4. The genetics of osteoporosis
5. Calcium supplementation and increases in bone mineral density in children
6. Prediction of bone density from vitamin D receptor alleles
7. Differential changes in bone mineral density of the appendicular and axial skeleton with aging
8. Trabecular bone architecture in the pathogenesis and prevention of fracture
9. Relationship between surface, volume, and thickness of iliac trabecular bone on aging and in osteoporosis: Implications for the microanatomic and cellular mechanism of bone loss
10. Age-related structural changes in trabecular and cortical bone: Cellular mechanism and biomechanical consequences. (a) Difference between rapid and slow bone loss. (b) Localized bone gain
11. Bone remodeling in the pathogenesis of osteoporosis
12. Simple measurements of femoral geometry predict hip fracture
13. A multifactorial intervention to reduce the risk of falling among elderly people living in the community
14. Falls
15. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis
16. Calcium nutrition and bone health in the elderly
17. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women
18. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients
19. Calcium requirement and calcium therapy
20. Menopausal changes in bone remodeling
21. Bone status and fracture rates in two regions of Yugoslavia
22. Vitamin D3 and calcium to prevent hip fractures in elderly women
23. Lactase deficiency. Prevalence in osteoporosis
24. Densities of bones of white and negro skeletons
25. Ethnic differences in hip fracture incidence in Bexar County
26. Genetic factors in determining bone mass
27. Comparative skeletal mass and radial bone mineral content in black and white women
28. Genetic factors in bone turnover
29. Contribution of transacting factor alleles to normal physiological variability: Vitamin D receptor polymorphism and circulating osteocalcin
30. Osteoporosis of the slender smoker: Vertebral compressiion fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity
31. Risk factors for spinal osteoporosis in men
32. Pregnancy and lactatiion as risk factors for subsequent bone loss and osteoporosis
33. Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment
34. Prevention of spinal osteoporosis in oophorectomised women
35. Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis
36. The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women
37. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: Effect of age and dietary calcium
38. Impaired vitamin D metabolism with aging in women: Possible role in pathogenesis of senile osteoporosis
39. 3 by kidney of rat
40. Bone density at various sites for prediction of hip fractures
41. Plasma calcitonin in normal man: Differences between men and women
42. Influence of age and sex on plasma calcitonin in human beings
43. Estimates of circulating monomeric calcitonin: Physiological studies in normal and thyroidectomized man
44. Transformed growth factor β inhibits bone resorption in fetal rat long bone cultures
45. Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts
46. Infusions of recombinant human interleukin-1α and β cause hypercalcemia in normal mice
47. Effects of interleukin-1 on bone turnover in normal mice
48. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release
49. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
50. Tumors producing human TNF induce hypercalcemia and osteoclastic bone resorption in nude mice
51. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption
52. Production of the bone resorbing cytokine lymphotoxin by cultured human myeloma cells
53. Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism
54. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse
55. Interleukin I8 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor
56. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
57. Isolatiion of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
58. TRANCE (tumor necrosis factor (TNF)-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
59. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
60. Interleukin-6 is produced by bone and modulated by parathyroid hormone
61. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude miice
62. IL-6 is produced by osteoblasts and induces bone resorption
63. Increased osteoclast development after estrogen loss - Mediation by interleukin-6
64. Actions of recombinant interleukin-1, interleukin-2 and interferon gamma on bone resorption in vitro
65. Preferential inhibition of cytokine stimulated bone resorption by recombinant interferon gamma
66. Osteoclast like formation in fetal and newborn long term baboon marrow cultures is more sensitive to 1,25-dihydroxyvitamin D3 than adult long term marrow cultures
67. Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures
68. In vivo stimulation of bone formation by transforming growth factor-beta
69. Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice
70. Psychotropic drug use and the risk of hip fracture
71. Risk factors for hip fracture
72. Osteoporosis
73. In women dietary calcium intake and rates of bone loss from midradius and lumbar spine are not related
74. A model for involutional bone loss
75. Relation between smoking and age of natural menopause
76. Changes in bone mass with age and alcoholism
77. Bone density in athletes
78. Life-style and bone mineral mass in perimenopausal women
79. Prevention of involutional bone loss by exercise
80. Physical exercise as prophylaxis against involutional vertebral bone loss: A controlled trial
81. Limitations of forearm bone densitometry as an index of vertebral or femoral neck osteopenia
82. Changes in bone turnover in young women consuming different levels of dietary protein
83. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism
84. Dietary protein intake and urinary excretion of calcium: A cross-sectional study in a healthy Japanese population
85. Protein consumption and bone fractures in women
86. Variable effects of tyrosine kinase inhibitors on ovarian osteoclastic activity and reduction of bone loss in ovariectomized rats
87. Inhibitory effect of genistein on bone resorption in tissue culture
88. Selective effects of genistein, a soybean isoflavones, on B-lymphopoiesis and bone loss caused by estrogen deficiency
89. The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis
90. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis
91. Role of soy protein with normal or reduced isoflavones content in reversing bone loss induced by ovarian hormone deficiency in rats
92. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavones content
93. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model
94. Long term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolaemic, postmenopausal women